White Paper – The Business Case for a Circular MedTech Sector

In Insights

15 April, 2021

This whitepaper demonstrates that the efforts of private companies towards circularity can in fact lead to a more sustainable medtech sector. Sustainable solutions in the field have the potential to not only reduce greenhouse gas emissions, but importantly also address a range of issues related to pollution and waste.

The effects should benefit natural environments and human health alike, and bring the industry in line with the scope of international agreements on sustainability such as the Paris Agreement of 2015. The move towards circularity constitutes a solid business case for competitive medtech companies.

This whitepaper is a result of a joint effort between AWA, Green Innovation Group and Matter.

The Business Case for a Circular MedTech Sector

Download White Paper

Send download link to:

You may also be interested in:

MedTrace receives $30 million investment fuelling US expansion and new business area

AWA’s client MedTrace Pharma A/S has received nearly $30 million from Swiss-based Swisscanto Invest and Danish investors ATP and

Read more...

Lego’s compensation increased tenfold by appeal court

On 1 April 2020 the Guangdong Higher People’s Court announced that it had awarded Danish toymaker Lego Rmb30 million

Read more...

China’s president pledges stronger IP enforcement

China’s president Xi Jinping has reiterated the country’s commitment to strengthening intellectual property protection and enforcement through higher damages

Read more...

Mobile Sliding Menu